Understanding MyNICaS Technology
Imperceptible electrical signal transmitted through the blood in the arterial system is recorded by using two sensors arranged in a wrist-to-ankle configuration.
Changes of arterial blood volume throughout the cardiovascular cycle results in a change in the body electrical resistance.
Cardiac Output, alongside other hemodynamic and fluid parameters, are calculated by proprietary algorithms.
Each qualified patient receives a personalized easy-to-read report. This report is immediately available and helps guide clinicians on how to adjust patient's medications and monitor progress over time.
Visual Assessment Process
The MyNICaS system provides a seamless, patient-friendly assessment experience. The non-invasive procedure requires no special patient preparation, causes no discomfort, and delivers comprehensive results within minutes. Healthcare providers can immediately review detailed cardiovascular metrics and make informed clinical decisions at the point of care.
Evidence-Based Clinical Success
MyNICaS technology is supported by extensive clinical validation and real-world evidence demonstrating significant improvements in patient outcomes across multiple cardiovascular conditions. Our comprehensive research portfolio includes peer-reviewed studies and clinical implementation reports from leading healthcare organizations.
Hypertension Management Excellence
Ohio Group Practice Achieves 92.9% Success in Management of 13,575 Hypertension Patients
This landmark study demonstrates the effectiveness of MyNICaS-guided medication management in achieving optimal blood pressure control across a large patient population.
CHF Readmission Reduction
Clinical Study Letter from Dr. Askari
MyNICaS provides highly accurate real-time data of the patient's cardiovascular status in just 3 minutes, enabling proactive intervention and significantly reducing hospital readmissions for congestive heart failure patients.
Pregnancy Hypertension Treatment
OB-GYN: Treatment of Chronic Hypertension in Pregnancy
MyNICaS enables safe, effective management of maternal hypertension with real-time cardiovascular monitoring that protects both mother and baby throughout pregnancy.
How the System Works
MyNICaS transmits a small, imperceptible electrical signal through the body via two electrical sensors arranged in a wrist-ankle configuration. This signal path enables calculation of stroke volume using our proprietary algorithm. Cardiac output is then calculated by multiplying stroke volume by heart rate, which is measured simultaneously using a standard three-lead ECG connection.
The system provides highly accurate data that correlates strongly with pulmonary artery catheter measurements, considered the gold standard for hemodynamic monitoring. This correlation ensures that MyNICaS delivers consistent, reliable, and real-time data about cardiovascular physiology without the risks and complications associated with invasive procedures.
FDA Cleared
MyNICaS products are FDA cleared and CE marked, meeting the highest international standards for medical device safety and efficacy. This regulatory approval reflects our commitment to delivering reliable, clinically validated technology to healthcare providers worldwide.
System Components and Setup
The MyNICaS system features an intuitive design that enables rapid deployment across clinical settings. Healthcare providers appreciate the straightforward setup process and the system's portability, which supports point-of-care testing in diverse environments from hospital wards to outpatient clinics and telemedicine applications.
